Zobrazeno 1 - 10
of 72
pro vyhledávání: '"A Rezazadeh Ardabili"'
Autor:
Janssen, L. M.1,2 (AUTHOR) laura.janssen@maastrichtuniversity.nl, Rezazadeh Ardabili, A.1,2 (AUTHOR), Romberg‐Camps, M. J. L.3 (AUTHOR), Winkens, B.4,5 (AUTHOR), van den Broek, R. J.1 (AUTHOR), Hulst, J.1 (AUTHOR), Verwijs, H. J. A.1 (AUTHOR), Keszthelyi, D.1,2 (AUTHOR), Jonkers, D. M. A. E.1,2 (AUTHOR), van Bodegraven, A. A.3 (AUTHOR), Pierik, M. J.1,2 (AUTHOR), Mujagic, Z.1,2 (AUTHOR)
Publikováno v:
Alimentary Pharmacology & Therapeutics. Nov2023, Vol. 58 Issue 10, p1041-1051. 11p.
Autor:
Aliu, Arta, Bosch, Daan H. C. A., Keszthelyi, Daniel, Rezazadeh Ardabili, Ashkan, Colombel, Jean‐Frederic, Sawyer, Rachel, Törnblom, Hans, Hart, Ailsa, Jonkers, Daisy M. A. E., Pierik, Marieke J., Mujagic, Zlatan
Publikováno v:
Alimentary Pharmacology & Therapeutics; Jun2024, Vol. 59 Issue 12, p1470-1488, 19p
Autor:
Rezazadeh Ardabili, Ashkan1,2 (AUTHOR) a.rezazadehardabili@maastrichtuniversity.nl, Jeuring, Steven1 (AUTHOR), Mujagic, Zlatan1,2 (AUTHOR), Oostenbrug, Liekele3 (AUTHOR), Romberg‐Camps, Mariëlle3 (AUTHOR), Jonkers, Daisy1,2 (AUTHOR), van Bodegraven, Adriaan3 (AUTHOR), Pierik, Marieke1,2 (AUTHOR)
Publikováno v:
Alimentary Pharmacology & Therapeutics. Sep2022, Vol. 56 Issue 6, p1030-1043. 14p. 2 Diagrams, 5 Charts, 2 Graphs.
Autor:
Rob H Creemers, Ashkan Rezazadeh Ardabili, Daisy M Jonkers, Mathie P G Leers, Mariëlle J Romberg-Camps, Marie J Pierik, Ad A van Bodegraven
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0258271 (2021)
ObjectiveData on the course of severe COVID-19 in inflammatory bowel disease (IBD) patients remains limited. We aimed to determine the incidence rate and clinical course of severe COVID-19 in the heavily affected South-Limburg region in the Netherlan
Externí odkaz:
https://doaj.org/article/b08a7013f9574e53a736557758fdb14c
Autor:
A Rezazadeh Ardabili, D van Esser, D Wintjens, M Cilissen, D Deben, Z Mujagic, F Russ, L Stassen, A van Bodegraven, D Wong, B Winkens, D Jonkers, M Romberg-Camps, M Pierik
Publikováno v:
Journal of Crohn's and Colitis. 17:i631-i634
Background Immunomodulators and biologicals are essential in current IBD management, but are associated with increased risk of infections. Considering the growing number of treatment options, the benefit-risk balance of drugs is becoming increasingly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e09e2e910872420ba9795a7ec47deda9
https://doi.org/10.1093/ecco-jcc/jjac190.0633
https://doi.org/10.1093/ecco-jcc/jjac190.0633
Autor:
K Demers, A Rezazadeh Ardabili, B C Bongers, M J L Romberg-Camps, A A van Bodegraven, D M A E Jonkers, M J Pierik, L P S Stassen
Publikováno v:
Journal of Crohn's and Colitis. 17:i362-i364
Background Cardiorespiratory fitness (CRF) as a potential predictor of disease outcome in Inflammatory Bowel Disease (IBD) is understudied, as are risk factors for impaired CRF. Lifestyle interventions focusing on improving CRF may aid in enhancing s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24e0a4f0091c8c37e65e2525222f8b97
https://doi.org/10.1093/ecco-jcc/jjac190.0341
https://doi.org/10.1093/ecco-jcc/jjac190.0341
Autor:
Creemers, Rob H.1,2 (AUTHOR) r.creemers@zuyderland.nl, Rezazadeh Ardabili, Ashkan2,3 (AUTHOR), Jonkers, Daisy M.2,3 (AUTHOR), Leers, Mathie P. G.4 (AUTHOR), Romberg-Camps, Mariëlle J.1 (AUTHOR), Pierik, Marie J.2,3 (AUTHOR), van Bodegraven, Ad A.1 (AUTHOR)
Publikováno v:
PLoS ONE. 10/5/2021, Vol. 16 Issue 10, p1-8. 8p.
Autor:
Kai Markus Schneider, Niklas Blank, Yelina Alvarez, Katharina Thum, Patrick Lundgren, Lev Litichevskiy, Madeleine Sleeman, Klaas Bahnsen, Jihee Kim, Simon Kardo, Shaan Patel, Lenka Dohnalová, Giulia T. Uhr, Hélène C. Descamps, Susanna Kircher, Alana M. McSween, Ashkan Rezazadeh Ardabili, Kelsey M. Nemec, Monica T. Jimenez, Lila G. Glotfelty, Joshua D. Eisenberg, Emma E. Furth, Jorge Henao-Mejia, F. Chris Bennett, Marie J. Pierik, Mariëlle Romberg-Camps, Zlatan Mujagic, Marco Prinz, Carolin V. Schneider, E. John Wherry, Meenakshi Bewtra, Robert O. Heuckeroth, Maayan Levy, Christoph A. Thaiss
Publikováno v:
Cell.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b34facc84470b080e70f04386819af5f
https://doi.org/10.1016/j.cell.2023.05.001
https://doi.org/10.1016/j.cell.2023.05.001
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ashkan Rezazadeh Ardabili, Dirk van Esser, Dion Wintjens, Mia Cilissen, Debbie Deben, Zlatan Mujagic, Fritzi Russ, Laurents Stassen, Adriaan A Van Bodegraven, Dennis Wong, Bjorn Winkens, Daisy Jonkers, Mariëlle Romberg-Camps, Marie J Pierik
Publikováno v:
Journal of Crohn's & Colitis.
Background Immunomodulators and biologics are cornerstones in the management of inflammatory bowel disease [IBD], but are associated with increased risk of infections. Post-marketing surveillance registries are pivotal to assess this risk, yet mainly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c8410149cce7662d9ef295fb2b3fca
https://doi.org/10.1093/ecco-jcc/jjad023
https://doi.org/10.1093/ecco-jcc/jjad023